Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-07

FDA Approved: TOBRAMYCIN AND DEXAMETHASONE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

Supplemental FDA approval for tobramycin and dexamethasone (Sandoz) as an ophthalmic combination product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TOBRAMYCIN AND DEXAMETHASONE (tobramycin and dexamethasone)

Snippet

SUPPL AP for TOBRAMYCIN AND DEXAMETHASONE (TOBRAMYCIN AND DEXAMETHASONE)